I'll say on the front end it involves discussion of mouse studies which I know is controversial, but hopefully there is some meaningful data gleaned from mouse studies or they'd stop doing them, wouldn't they?
Anyway, I found this information very interesting.
Here is one nugget from the piece:
"While Dr. Klotz thought this analysis would disprove Morote’s conclusion, in actuality, the results of the analysis vindicated Morote’s observation that that lower nadir testosterone in the first year of ADT correlates with a low time to CRPC and improved cause-specific survival."
Written by
SuppWife
To view profiles and participate in discussions please or .
The studies showing that achieving lower levels of testosterone with ADT results in longer survival and delayed progression were clinical studies, not a mouse study.
I know this tread is about T but although I can't quite recall the details but in relation to a quick PSA non detectable rate after commencing hormones wasn't there a study done in China that said those in this category had shorter survival time??
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.